Michael Aaron Kelly
Director · 4 filings · Latest: Jun 5, 2026
AMICUS THERAPEUTICS, INC.
DMC Global Inc.
NEOGENOMICS INC
Prime Medicine, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NEO | Michael Aaron Kelly | Director | Jun 1, 2026 | Option Exercise | $0.00 | 23,077 | — | 67,086 |